Navigation Links
,,Alternative Therapy in HIV Patients

As more HIV-infected patients turn to complementary and alternative medicine, researchers have set out to determine the prevalence and factors associated with such use.

In this study, researchers evaluated CAM use among nearly 3,000 patients enrolled in the HIV Cost and Services Utilization Study. Using this sample of patients who received conventional HIV care, researchers determined demographic and clinical characteristics of people with HIV. Approximately six months later, the use of CAM was determined during a follow-up// survey..
Researchers used data from interviews and surveys to determine the prevalence of CAM use, CAM use with potential for adverse effects, and CAM use as a substitute for conventional HIV therapy.
Results show 53 percent of patients reported using at least one type of CAM during the course of the study. The four most commonly used methods were relaxation, spiritual healing, self-help and herbal medicine. More than one-fourth of the patients used CAM with the potential for side effects and 3 percent reported using CAM in lieu of conventional HIV therapy. More than one-half of the patients using CAM had not discussed it with their health care providers. Findings from the study show HIV-infected patients who desired medical information and involvement in medical decision-making were most likely to use CAM. Researchers suggest a need for a health care setting that encourages open discussion between health care providers and patients. They say, "Improved physician understanding about patients' need for control over their own health care and the benefits and risks of CAM in HIV care may open channels of communication."

Researchers conclude that with one quarter of HIV-infected patients using CAM at the risk of potential side affects, physicians should openly ask their patients about such use. They suggest displaying a nonjudgmental attitude toward CAM may encourage patients to accurately report their use , thereby preventing unnecessary adverse effects.

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: